Rena Pollack

Predictors of diabetic ketoacidosis in patients with insulin‐deficient diabetes phenotype initiating <scp>SGLT2</scp> inhibitors

Kidney outcomes with <scp>SGLT2</scp> inhibitors in patients with diabetes and an insulin‐deficient phenotype: A real world analysis

Cardiovascular outcomes of romosozumab treatment—real-world data analysis

Complex rearrangement in TBC1D4 in an individual with diabetes due to severe insulin resistance syndrome

Future diabetes risk can be predicted by the number of abnormal oral glucose tolerance test values during pregnancy

VA-ECMO for Thyroid Storm: Case Reports and Review of the Literature.

RNA Sequencing Reveals Unique Transcriptomic Signatures of the Thyroid in a Murine Lung Cancer Model Treated with PD-1 and PD-L1 Antibodies

SGLT2 Inhibitors and Safety in Older Patients

Consistency of Thyroid Imaging Reporting and Data System Reporting in Community-Based Imaging Centers Versus a Large Tertiary Hospital

Efficacy and Safety of Dapagliflozin by Baseline Insulin Regimen and Dose: Post Hoc Analyses From DECLARE-TIMI 58

Immune Checkpoint Inhibitor-induced Thyroid Dysfunction Is Associated with Higher Body Mass Index

Role of Cannulated Prolactin Test in Evaluation of Hyperprolactinemia - A Retrospective Study

Impact of flash glucose monitoring on glucose control and hospitalization in type 1 diabetes: A nationwide cohort study

PD-L1 Expression in Normal Endocrine Tissues Is Not Increased Despite High Incidence of PD-1 Inhibitor-Associated Endocrinopathies

Baseline TSH Level is Associated with Risk of Anti–PD-1–Induced Thyroid Dysfunction

Association of Inpatient Glucose Measurements With Amputations in Patients Hospitalized With Acute Diabetic Foot

Acute renal outcomes with sodium‐glucose co‐transporter‐2 inhibitors: Real‐world data analysis

Validity of diagnostic codes and estimation of prevalence of diabetic foot ulcers using a large electronic medical record database

Resveratrol Improves Vascular Function and Mitochondrial Number but Not Glucose Metabolism in Older Adults

Treatment of Type 2 Diabetes: From “Guidelines” to “Position Statements” and Back